BOC Sciences Press Releases & News

BOC Sciences Reports Strong Capabilities of CDMO Operations

BOC Sciences, one of the front-runners in chemical material manufacturing and custom services for the full drug product lifecycle, today reported strong growth over the past year in its expanded contract development and manufacturing (CDMO) platform. - May 10, 2023

BOC Sciences Unveils Comprehensive Capabilities of Custom Peptide Drug Conjugate

BOC Sciences unveils its comprehensive capabilities of custom peptide drug conjugate from project design to commercial production. - May 09, 2023

BOC Sciences Confirms Bulk Offering of Pharmaceutical Impurities for Global Partners

In the wake of the COVID-19 pandemic, BOC Sciences, the world's reputed chemical supplier, declares that it will increase production to offer pharmaceutical impurity standards in bulk to satisfy unmet demands. - April 20, 2023

BOC Sciences Rolled Out PEG GMP Manufacture Services for Broad Applications

BOC Sciences recently launched the PEG GMP manufacture service, a novel solution that aims at providing GMP-grade PEG products for a wide scope of applications. - December 30, 2022

BOC Sciences: ADC Analysis and Characterization Support Development, Registration, and Release

BOC Sciences announces support for antibody-drug conjugate (ADC) development, registration, and release by providing a comprehensive set of analysis and characterization technologies. - November 11, 2022

BOC Sciences Makes Easy Access to Polymerization Tech

Owing to the continuously upgraded synthesis technologies and analytical abilities, BOC Sciences has performed well in the polymer industry, serving the community with a comprehensive product portfolio and valuable technical support. - November 11, 2022

High-Standard Fermented Raw Materials That Satisfy the Quality Attributes of Healthcare Products

BOC Sciences is able to provide clients with high-standard fermented raw materials that satisfy the quality attributes of finished healthcare products. - October 13, 2022

BOC Sciences Declares the Availability of 10,000 Impurities, All in Stock

BOC Sciences recently confirmed to its customers that over 10,000 impurities are now in stock, ready for immediate delivery. - October 12, 2022

BOC Sciences September Promotion: Comprehensive Labeled Peptides with Stable Quality

As a pioneer in stable isotopic labeling chemistry, BOC Sciences develops a large variety of SIL compounds. Its promotion of labeled peptides, the increasingly used materials for convenient detection in research, is on the boil in September. - September 14, 2022

BOC Sciences Yields Peptide-siRNA Conjugates of High Quality

BOC Sciences offers high-quality peptide-siRNA conjugates to help clients achieve substantial preclinical progress for RNAi therapeutics. - September 07, 2022

BOC Sciences Developed Strain Expression Systems to Enhance Fermentation Productivity

BOC Sciences developed strain expression systems for fermentation to help researchers greatly enhance fermentation productivity while significantly reducing costs. - September 02, 2022

Stable and Quality Supply of Phosphoramidites is a Reality at BOC Sciences

As an expert in chemistry, BOC Sciences understands how important the quality of phosphoramidite is to successful oligo synthesis and remarkably, it has taken concrete actions to manufacture certified products. - August 05, 2022

BOC Sciences Shares Its Strategic Emphasis on NTPs During the Pandemic

"Whether your studies involve DNA sequencing, cDNA synthesis, RT-PCR, RCA, MDA, DNA labeling, in vitro transcription, siRNA synthesis, or RNA amplification, we stock hundreds of modified or natural NTPs to suit your various molecular biological applications," a BOC Sciences manager announces to the public. - August 05, 2022

BOC Sciences Grandly Promotes: One-Stop CDMO Service Platform for Drug Development

BOC Sciences recently initiated an unprecedentedly comprehensive CDMO service platform to accelerate the technology transfer of medicines from research to commercial production. - July 06, 2022

BOC Sciences Commitment at BIO 2022: From Concept to GMP Production

The BIO International Convention just ended on June 16 at San Diego Convention Center. BOC Sciences exhibited a whole set of preclinical CRO & fermentation CDMO services and attracted many interested visitors stopping by to have an informative in-person meeting. - July 06, 2022

BOC Sciences Officially Releases the Final Invitation to Renowned Pharma Conferences in May

As the two industry-renowned exhibitions—CPhI North America and TIDES USA 2022 draw near, BOC Sciences is making final efforts to let the news reach as many researchers as possible, especially those who are struggling to find the best mRNA services. - May 23, 2022

Carbohydrates of BOC Sciences Reveal Myriad Possibilities for Therapeutics

BOC Sciences updated several carbohydrates and derivatives in July 2020 and has kept a constant enlargement of product categories since then. Currently, it provides a full spectrum of carbohydrates that dramatically boost the research in Glycochemistry, Glycobiology, Glyco-analytics, and other Glycosciences. - May 23, 2022

BOC Sciences